Advisors Asset Management Inc. Sells 166 Shares of Chemed Co. (NYSE:CHE)

Advisors Asset Management Inc. reduced its stake in Chemed Co. (NYSE:CHE) by 4.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,328 shares of the company’s stock after selling 166 shares during the quarter. Advisors Asset Management Inc.’s holdings in Chemed were worth $2,000,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of the stock. GAMMA Investing LLC grew its position in Chemed by 34.4% in the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after acquiring an additional 22 shares in the last quarter. Ballentine Partners LLC boosted its holdings in shares of Chemed by 4.1% in the 3rd quarter. Ballentine Partners LLC now owns 655 shares of the company’s stock worth $394,000 after purchasing an additional 26 shares in the last quarter. Everpar Advisors LLC increased its position in shares of Chemed by 4.9% during the 2nd quarter. Everpar Advisors LLC now owns 580 shares of the company’s stock valued at $315,000 after purchasing an additional 27 shares during the last quarter. Creative Planning boosted its stake in Chemed by 2.8% in the second quarter. Creative Planning now owns 1,228 shares of the company’s stock worth $667,000 after buying an additional 34 shares in the last quarter. Finally, First Heartland Consultants Inc. raised its stake in shares of Chemed by 7.2% during the third quarter. First Heartland Consultants Inc. now owns 508 shares of the company’s stock worth $305,000 after acquiring an additional 34 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Chemed Stock Performance

NYSE CHE opened at $570.96 on Monday. Chemed Co. has a fifty-two week low of $523.33 and a fifty-two week high of $654.62. The stock has a market cap of $8.59 billion, a P/E ratio of 28.85, a price-to-earnings-growth ratio of 2.39 and a beta of 0.46. The stock has a 50 day simple moving average of $579.08 and a two-hundred day simple moving average of $565.00.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The company had revenue of $606.18 million for the quarter, compared to analysts’ expectations of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.32 earnings per share. Sell-side analysts predict that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Monday, November 18th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. The ex-dividend date is Monday, November 18th. Chemed’s dividend payout ratio is currently 10.11%.

Analysts Set New Price Targets

CHE has been the subject of a number of research reports. Royal Bank of Canada reduced their target price on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a report on Tuesday, November 5th. StockNews.com cut Chemed from a “buy” rating to a “hold” rating in a report on Friday.

Insider Activity

In other Chemed news, Director George J. Walsh III sold 400 shares of the company’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $597.47, for a total value of $238,988.00. Following the sale, the director now owns 3,046 shares in the company, valued at approximately $1,819,893.62. This represents a 11.61 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the transaction, the chief executive officer now directly owns 103,735 shares of the company’s stock, valued at $62,117,555.35. This represents a 1.89 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 4,113 shares of company stock worth $2,411,905 in the last quarter. 3.32% of the stock is owned by company insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.